GNH USA

Europe — EMA

Oczyesa (Octreotide)

Octreotide, the active ingredient in Oczyesa, is a somatostatin analogue presented as a strength/form for subcutaneous injection use. It treats symptoms associated with hormonal hypersecretion and certain tumor types in…

Request sourcing

1
Pack/s

What is Octreotide?

Octreotide, the active ingredient in Oczyesa, is a somatostatin analogue presented as a strength/form for subcutaneous injection use. It treats symptoms associated with hormonal hypersecretion and certain tumor types in adult patients. GNH USA supplies Oczyesa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oczyesa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

What is Octreotide used for?

Oczyesa is a synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic synthetic syntits ....

What are the side effects of Octreotide?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Octreotide
Route
Subcutaneous Use
Manufacturer
Camurus Ab
Origin
EU

Related products